Samuel Lee

Samuel Lee, MD, MBA, is the Co-Founder and President of Eikonoklastes Therapeutics, which focuses on advancing innovative treatments for neurodegenerative diseases. They have also served as an angel investor for multiple companies, including Swift Solar and American Gene Technologies. Samuel has held various board positions and research roles at organizations like XII Medical, Cincinnati Children's Hospital Medical Center, and Johns Hopkins Medicine. Currently, they are pursuing degrees in Business Administration and Entrepreneurship at Stanford University Graduate School of Business and in Medicine at the University of Cincinnati.